Status:
COMPLETED
Update of the EORTC QLQ-LC13 Quality of Life Questionnaire
Lead Sponsor:
Michael Koller
Collaborating Sponsors:
Hospital of Navarra
Oslo University Hospital
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Lung Cancer 13 (EORTC QLQ-LC13) is considered as a standard instrument to assess the quality of life (QL) o...
Detailed Description
The project follows the EORTC model of module development and covers the first three phases: Phase I This phase is aimed at compiling an extensive list of quality of life issues relevant for lung can...
Eligibility Criteria
Inclusion
- confirmed diagnosis of lung cancer
- informed consent
- capability to respond to a questionnaire and to follow an interview
Exclusion
- no informed consent
- lack of capability to respond to a questionnaire
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01434784
Start Date
September 1 2011
End Date
January 1 2015
Last Update
June 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Clinical Studies, University Hospital Regensburg
Regensburg, Germany